Company intelligence / Profile preview
Sekkei Bio
- Ownership
- Private
- Development stage
- Preclinical
Overview
Sekkei Bio is an innovation-driven biopharmaceutical company focused on developing novel medicines for global unmet needs. Its proprietary platforms enable the design of multi-targeted drugs for polygenic diseases as well as next-generation mRNA-based therapeutics. The company has demonstrated proof-of-concept with SARS-CoV‑2 vaccine candidates similar to Pfizer-BioNTech/Moderna but is now advancing second-generation RNA technologies aimed at affordability and access. It also works on oral insulin delivery, thermostable insulin formulations, non-opioid analgesics, RSV combination vaccines, and nonhormonal contraceptive targets. Some programs have received funding from the Bill & Melinda Gates Foundation.
- Therapeutic areas
- Metabolic DisordersNeurologyInfectious Diseases
- Modalities
- Small moleculesPeptidesmRNA therapeutics and vaccinesBiologics (including monoclonal antibodies via mRNA)
- Industry
- Biotech
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Sekkei Bio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sekkei Bio.